All eyes are on the fate of the AstraZeneca vaccine today, with EU drug regulators set to announce their findings about possible links between the jab and rare blood clots,
6 months after a COVID-19 diagnosis, 1 in 3 patients are diagnosed with a neuropsychiatric condition, according to a large
Our immune response to SARS-CoV-2 centers on the virus’s spike protein. All 3 COVID vaccines authorized in the US are based on a modified version of spike called 2P. A new, more resilient version called HexaPro may be even better.
Liberia is the first African country to introduce the new typhoid conjugate vaccine, folding it into routine immunizations for 9-month-olds, the
A speedy vaccine rollout is Bangladesh’s shining victory during the pandemic, but there aren’t enough takers for the shots, says Taufique Joarder, MBBS, DrPH, MPH, executive director of the Public Health Foundation, Bangladesh. Even as the country negotiated quick access to…
India topped more than 100,000 COVID-19 cases per day yesterday and potentially faces an “out of control” virus,
Last October, residents in 2 Nigerian states reported deaths from a “strange disease.” Yellow fever had previously spared Enugu and Delta states so some residents blamed spiritual causes for the deaths.
The UK is set to offer the entire population twice-a-week testing beginning on Friday, though the plan is drawing fire from critics. Different takes:
The AstraZeneca/Oxford University vaccine’s troubled ride through recent weeks has run into new doubts as
As COVID-19 vaccinations speed up, herd immunity is the talk of the town. However, some key factors are making it difficult to pinpoint the percentage of immunized people needed to reach herd immunity. They include the emergence of virus variants and whether vaccines can…